ID   HTRA1_MOUSE             Reviewed;         480 AA.
AC   Q9R118; Q8BN04; Q8BN05; Q91WS3; Q9QZK6;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   04-FEB-2015, entry version 120.
DE   RecName: Full=Serine protease HTRA1;
DE            EC=3.4.21.-;
DE   AltName: Full=High-temperature requirement A serine peptidase 1;
DE   AltName: Full=Serine protease 11;
DE   Flags: Precursor;
GN   Name=Htra1; Synonyms=Htra, Prss11;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH BMP4; TGFB2;
RP   TGFB1; ACTIVIN A AND GDF5, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND MUTAGENESIS OF SER-328.
RC   STRAIN=ICR; TISSUE=Brain;
RX   PubMed=14973287; DOI=10.1242/dev.00999;
RA   Oka C., Tsujimoto R., Kajikawa M., Koshiba-Takeuchi K., Ina J.,
RA   Yano M., Tsuchiya A., Ueta Y., Soma A., Kanda H., Matsumoto M.,
RA   Kawaichi M.;
RT   "HtrA1 serine protease inhibits signaling mediated by Tgfbeta family
RT   proteins.";
RL   Development 131:1041-1053(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6; TISSUE=Ovary;
RA   Hourvitz A., Hennebold J.D., King G., Negishi H., Erickson G.F.,
RA   Roby J.A., Mayo K.E., Adashi E.Y.;
RT   "Mouse insulin-like growth factor binding protein 5-directed
RT   endopeptidase: structural assessment, evolutionary analysis, ovarian
RT   expression, hormonal regulation and cellular localization.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 73-480.
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [6]
RP   MUTAGENESIS OF PHE-171.
RX   PubMed=15101818; DOI=10.1042/BJ20040435;
RA   Murwantoko I., Yano M., Ueta Y., Murasaki A., Kanda H., Oka C.,
RA   Kawaichi M.;
RT   "Binding of proteins to the PDZ domain regulates proteolytic activity
RT   of HtrA1 serine protease.";
RL   Biochem. J. 381:895-904(2004).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15993670; DOI=10.1016/j.bone.2005.03.015;
RA   Tsuchiya A., Yano M., Tocharus J., Kojima H., Fukumoto M.,
RA   Kawaichi M., Oka C.;
RT   "Expression of mouse HtrA1 serine protease in normal bone and
RT   cartilage and its upregulation in joint cartilage damaged by
RT   experimental arthritis.";
RL   Bone 37:323-336(2005).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=18551132; DOI=10.1038/cdd.2008.82;
RA   Launay S., Maubert E., Lebeurrier N., Tennstaedt A., Campioni M.,
RA   Docagne F., Gabriel C., Dauphinot L., Potier M.C., Ehrmann M.,
RA   Baldi A., Vivien D.;
RT   "HtrA1-dependent proteolysis of TGF-beta controls both neuronal
RT   maturation and developmental survival.";
RL   Cell Death Differ. 15:1408-1416(2008).
RN   [9]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=22049084; DOI=10.1074/jbc.M111.275990;
RA   Zhang L., Lim S.L., Du H., Zhang M., Kozak I., Hannum G., Wang X.,
RA   Ouyang H., Hughes G., Zhao L., Zhu X., Lee C., Su Z., Zhou X.,
RA   Shaw R., Geum D., Wei X., Zhu J., Ideker T., Oka C., Wang N., Yang Z.,
RA   Shaw P.X., Zhang K.;
RT   "High temperature requirement factor A1 (HTRA1) gene regulates
RT   angiogenesis through transforming growth factor-beta family member
RT   growth differentiation factor 6.";
RL   J. Biol. Chem. 287:1520-1526(2012).
CC   -!- FUNCTION: Serine protease with a variety of targets, including
CC       extracellular matrix proteins such as fibronectin. HTRA1-generated
CC       fibronectin fragments further induce synovial cells to up-regulate
CC       MMP1 and MMP3 production. May also degrade proteoglycans, such as
CC       aggrecan, decorin and fibromodulin. Through cleavage of
CC       proteoglycans, may release soluble FGF-glycosaminoglycan complexes
CC       that promote the range and intensity of FGF signals in the
CC       extracellular space. Regulates the availability of insulin-like
CC       growth factors (IGFs) by cleaving IGF-binding proteins. Inhibits
CC       signaling mediated by TGF-beta family members. This activity
CC       requires the integrity of the catalytic site, but it is unclear
CC       whether it leads to the proteolytic degradation of TGF-beta
CC       proteins themselves (PubMed:18551132) or not (PubMed:14973287). By
CC       acting on TGF-beta signaling, may regulate many physiological
CC       processes, including retinal angiogenesis and neuronal survival
CC       and maturation during development. Intracellularly, degrades TSC2,
CC       leading to the activation of TSC2 downstream targets.
CC       {ECO:0000269|PubMed:14973287, ECO:0000269|PubMed:15993670,
CC       ECO:0000269|PubMed:18551132, ECO:0000269|PubMed:22049084}.
CC   -!- SUBUNIT: Forms homotrimers. In the presence of substrate, may form
CC       higher-order multimers in a PDZ-independent manner (By
CC       similarity). Interacts with TGF-beta family members, including
CC       BMP4, TGFB1, TGFB2, activin A and GDF5. {ECO:0000250,
CC       ECO:0000269|PubMed:14973287}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Cytoplasm, cytosol
CC       {ECO:0000250}. Note=Predominantly secreted. Also found associated
CC       with the plasma membrane. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In the brain, mainly expressed in cortical
CC       areas both in glial cells and neurons (at protein level). In
CC       bones, deposited in the matrix, with higher level in newly formed
CC       bone compared to fully calcified bone (at protein level). Also
CC       expressed in the tendons (at protein level). In the articular
CC       cartilage, detected only in the deepest zone of the joint
CC       cartilage. Not detected in the chondrocytes of the growth plate
CC       (at protein level). In an experimental arthritis model, at early
CC       disease stages, up-regulated in articular chondrocytes in the deep
CC       layers of the cartilage (at protein level). As arthritis
CC       progresses, chondrocyte expression expands toward the surface.
CC       {ECO:0000269|PubMed:14973287, ECO:0000269|PubMed:15993670,
CC       ECO:0000269|PubMed:18551132}.
CC   -!- DEVELOPMENTAL STAGE: First detected at 10.5 dpc. At 11.5 dpc, in
CC       the developing heart, expressed in the atrioventricular
CC       endocardial cushion and the outflow tract (at protein level). At
CC       14.5 dpc, strong expression in the outflow tracts, including
CC       valves. In the developing skeleton, expressed at 12.5 dpc in the
CC       vertebral column and limbs. At 14.5 dpc, expressed in rudiments of
CC       tendons and ligaments along the vertebrae, as well as in
CC       mesenchymal cells surrounding precartilage condensations. Not
CC       detected in precartilage condensations, nor in chondrocytes, but
CC       strongly expressed in ossification centers. At 17.5 dpc, in the
CC       hind limb, significant expression persists in tendons and
CC       ligaments, but expression in the forming joints is reduced. At
CC       this stage, weakly detected in the thin layer of articular
CC       surfaces. Postnatally, in long bones, expressed by terminally
CC       differentiated hypertrophic chondrocytes that are committed to
CC       degeneration and eventually replaced by bone, as well as by
CC       osteoblasts at late differentiation stages and by mature
CC       osteocytes. In the developing brain, expressed in specific regions
CC       of the neuroepithelium in the forebrain and hindbrain adjacent to
CC       the forming choroid plexus. From 17.5 dpc till birth, expressed in
CC       neurogenic areas including ventricular zones (at protein level).
CC       At 12.5 and 14.5 dpc, expressed in Muellerian duct cells and in
CC       the surrounding mesenchyme in both male and female gonads. In the
CC       lung, detected in the mesenchymal cells. Expressed at 12.5 dpc in
CC       abdominal skin, both in epidermis and dermis. Also expressed in
CC       the epithelium of developing whiskers at 14.5 dpc. At later
CC       stages, localized in the basal layer of epidermis and in the
CC       invading epidermal cells that formed the whisker rudiments (at
CC       protein level). 9 days after birth, detected in the whisker outer
CC       root sheet (at protein level). {ECO:0000269|PubMed:14973287,
CC       ECO:0000269|PubMed:15993670, ECO:0000269|PubMed:18551132}.
CC   -!- DOMAIN: The IGFBP N-terminal domain mediates interaction with TSC2
CC       substrate. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mutants mice exhibit reduced retinal
CC       capillary density, as compared to wild type animals, in all 3
CC       retinal layers, nerve fiber layer, as well as inner and outer
CC       plexiform layers. {ECO:0000269|PubMed:22049084}.
CC   -!- SIMILARITY: Belongs to the peptidase S1C family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 IGFBP N-terminal domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00653}.
CC   -!- SIMILARITY: Contains 1 Kazal-like domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00798}.
CC   -!- SIMILARITY: Contains 1 PDZ (DHR) domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00143}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF172994; AAD49422.1; -; mRNA.
DR   EMBL; AF179369; AAD52682.1; -; mRNA.
DR   EMBL; CH466531; EDL17689.1; -; Genomic_DNA.
DR   EMBL; BC013516; AAH13516.1; -; mRNA.
DR   EMBL; AK090320; BAC41168.1; -; mRNA.
DR   EMBL; AK090321; BAC41169.1; -; mRNA.
DR   CCDS; CCDS21908.1; -.
DR   RefSeq; NP_062510.2; NM_019564.3.
DR   UniGene; Mm.30156; -.
DR   ProteinModelPortal; Q9R118; -.
DR   SMR; Q9R118; 37-154, 160-370, 380-480.
DR   BioGrid; 207847; 5.
DR   STRING; 10090.ENSMUSP00000006367; -.
DR   MEROPS; S01.277; -.
DR   PhosphoSite; Q9R118; -.
DR   MaxQB; Q9R118; -.
DR   PaxDb; Q9R118; -.
DR   PRIDE; Q9R118; -.
DR   Ensembl; ENSMUST00000006367; ENSMUSP00000006367; ENSMUSG00000006205.
DR   GeneID; 56213; -.
DR   KEGG; mmu:56213; -.
DR   UCSC; uc009kau.2; mouse.
DR   CTD; 5654; -.
DR   MGI; MGI:1929076; Htra1.
DR   eggNOG; COG0265; -.
DR   GeneTree; ENSGT00510000046315; -.
DR   HOGENOM; HOG000223641; -.
DR   HOVERGEN; HBG052044; -.
DR   InParanoid; Q9R118; -.
DR   KO; K08784; -.
DR   OMA; HKDFPDV; -.
DR   OrthoDB; EOG7V1FR7; -.
DR   TreeFam; TF323480; -.
DR   ChiTaRS; Htra1; mouse.
DR   NextBio; 312058; -.
DR   PRO; PR:Q9R118; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; Q9R118; -.
DR   CleanEx; MM_HTRA1; -.
DR   Genevestigator; Q9R118; -.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0031012; C:extracellular matrix; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular vesicular exosome; ISO:MGI.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0097187; P:dentinogenesis; IEA:Ensembl.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IDA:MGI.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:MGI.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; IEA:InterPro.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR009030; Growth_fac_rcpt_N_dom.
DR   InterPro; IPR000867; IGFBP-like.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR001940; Peptidase_S1C.
DR   InterPro; IPR009003; Trypsin-like_Pept_dom.
DR   Pfam; PF00219; IGFBP; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   PRINTS; PR00834; PROTEASES2C.
DR   SMART; SM00121; IB; 1.
DR   SMART; SM00280; KAZAL; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS51323; IGFBP_N_2; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Growth factor binding; Hydrolase;
KW   Protease; Reference proteome; Secreted; Serine protease; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    480       Serine protease HTRA1.
FT                                /FTId=PRO_0000026944.
FT   DOMAIN       33    100       IGFBP N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00653}.
FT   DOMAIN       98    157       Kazal-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00798}.
FT   DOMAIN      365    467       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   REGION      204    364       Serine protease.
FT   ACT_SITE    220    220       Charge relay system. {ECO:0000255}.
FT   ACT_SITE    250    250       Charge relay system. {ECO:0000255}.
FT   ACT_SITE    328    328       Charge relay system. {ECO:0000255}.
FT   SITE        169    169       Involved in trimer stabilization.
FT                                {ECO:0000250}.
FT   SITE        171    171       Involved in trimer stabilization.
FT                                {ECO:0000250}.
FT   SITE        278    278       Involved in trimer stabilization.
FT                                {ECO:0000250}.
FT   MUTAGEN     171    171       F->D: Loss of efficient trimer formation.
FT                                {ECO:0000269|PubMed:15101818}.
FT   MUTAGEN     328    328       S->A: Loss of enzymatic activity. No
FT                                effect on BMP4-binding.
FT                                {ECO:0000269|PubMed:14973287}.
FT   CONFLICT     91     91       V -> L (in Ref. 1; AAD49422).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       R -> P (in Ref. 1; AAD49422).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       I -> F (in Ref. 1; AAD49422).
FT                                {ECO:0000305}.
FT   CONFLICT    182    182       A -> D (in Ref. 1; AAD49422).
FT                                {ECO:0000305}.
FT   CONFLICT    185    186       HI -> KH (in Ref. 1; AAD49422).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       K -> I (in Ref. 1; AAD49422).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       Q -> K (in Ref. 5; BAC41168).
FT                                {ECO:0000305}.
FT   CONFLICT    366    366       E -> Q (in Ref. 4; AAH13516).
FT                                {ECO:0000305}.
SQ   SEQUENCE   480 AA;  51214 MW;  92BDDA85CF5B12B7 CRC64;
     MQSLRTTLLS LLLLLLAAPS LALPSGTGRS APAATVCPEH CDPTRCAPPP TDCEGGRVRD
     ACGCCEVCGA LEGAACGLQE GPCGEGLQCV VPFGVPASAT VRRRAQAGLC VCASSEPVCG
     SDAKTYTNLC QLRAASRRSE KLRQPPVIVL QRGACGQGQE DPNSLRHKYN FIADVVEKIA
     PAVVHIELYR KLPFSKREVP VASGSGFIVS EDGLIVTNAH VVTNKNRVKV ELKNGATYEA
     KIKDVDEKAD IALIKIDHQG KLPVLLLGRS SELRPGEFVV AIGSPFSLQN TVTTGIVSTT
     QRGGKELGLR NSDMDYIQTD AIINYGNSGG PLVNLDGEVI GINTLKVTAG ISFAIPSDKI
     KKFLTESHDR QAKGKAVTKK KYIGIRMMSL TSSKAKELKD RHRDFPDVLS GAYIIEVIPD
     TPAEAGGLKE NDVIISINGQ SVVTANDVSD VIKKENTLNM VVRRGNEDIV ITVIPEEIDP
//
